Repetitive intranasal application of human neural stem cells decreases neuroinflammation, and enhances neurogenesis and expression of beta-amyloid-degrading enzymes in a APP/PS1 mouse model of AD [228]. The gene discussed is APP; the disease is Alzheimer disease.